Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Scholar Rock Holding Corp (SRRK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/11/2023 8-K Quarterly results
08/09/2023 8-K Quarterly results
Docs: "Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress"
06/30/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy",
"Presentation Slide Deck"
05/09/2023 8-K Quarterly results
Docs: "Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress"
03/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress"
01/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation distributed by Scholar Rock Holding Corporation dated January 9, 2023, furnished hereto",
"Scholar Rock Provides Corporate Update and Highlights Priorities for 2023"
11/14/2022 8-K Quarterly results
Docs: "Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress"
11/09/2022 8-K Quarterly results
09/20/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "List of Board Positions Autolus Therapeutics Lava Therapeutics Be Biopharma Disc Medicine Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement 3 SCHOLAR ROCK, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement",
"Scholar Rock Appoints Jay Backstrom, M.D., M.P.H., to be its Next Chief Executive Officer"
08/08/2022 8-K Quarterly results
07/26/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/07/2022 8-K Quarterly results
01/10/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Scholar Rock Provides Corporate Update and Highlights Priorities for 2022",
"Presentation slide deck, furnished hereto"
11/30/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy"
11/17/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
11/09/2021 8-K Quarterly results
Docs: "Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress"
08/10/2021 8-K Quarterly results
08/03/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, by and between Scholar Rock, Inc. and Nagesh Mahanthappa",
"Scholar Rock Announces Leadership Change"
06/15/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/26/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
04/06/2021 8-K Quarterly results
03/18/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "Scholar Rock Reports Third Quarter 2020 Financial Results and Highlights Business Progress"
10/30/2020 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Scholar Rock Holding Corporation 2,948,718 Shares of Common Stock, par value $0.001 per share Pre-Funded Warrants to Purchase 2,179,487 Shares of Common Stock Underwriting Agreement",
"SCHOLAR ROCK HOLDING CORPORATION FORM OF WARRANT TO PURCHASE COMMON STOCK",
"100 Northern Avenue Boston, MA 02210",
"Scholar Rock Announces Proposed Public Offering of Common Stock",
"Scholar Rock Announces Pricing of Public Offering of Common Stock and Prefunded Warrants"
10/27/2020 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Scholar Rock Announces Positive Proof-of-Concept Data from TOPAZ Phase 2 Trial Interim Analysis of SRK-015 in Patients with Type 2 and Type 3 Spinal Muscular Atrophy",
"Presentation Slide Deck"
10/19/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy